Weight loss resistance is often driven by impaired metabolic signaling, inflammation, and disrupted gut-derived hormone pathways. This protocol leverages targeted peptide therapy to support appetite regulation, improve GLP-1 activity, and enhance cellular communication, while pairing with foundational detox and gut support. Designed for patients with weight loss resistance or metabolic dysfunction, it provides a synergistic approach to restore signaling and promote sustainable fat loss.